Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics ( (AU:PER) ) has provided an update.
Percheron Therapeutics Limited has announced the cessation of certain securities, specifically options that expired without being exercised or converted. A total of 14.5 million options, with varying exercise prices, have expired as of March 18, 2025. This announcement may impact the company’s capital structure and could influence investor perception regarding the company’s financial strategies.
More about Percheron Therapeutics
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.63M
See more data about PER stock on TipRanks’ Stock Analysis page.

